These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30850635)

  • 41. Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens.
    Laffer S; Duchene M; Reimitzer I; Susani M; Mannhalter C; Kraft D; Valenta R
    Mol Immunol; 1996; 33(4-5):417-26. PubMed ID: 8676893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
    Westritschnig K; Linhart B; Focke-Tejkl M; Pavkov T; Keller W; Ball T; Mari A; Hartl A; Stöcklinger A; Scheiblhofer S; Thalhamer J; Ferreira F; Vieths S; Vogel L; Böhm A; Valent P; Valenta R
    J Immunol; 2007 Dec; 179(11):7624-34. PubMed ID: 18025208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen.
    Rossi RE; Monasterolo G; Monasterolo S
    Allergy; 2001 Dec; 56(12):1180-5. PubMed ID: 11736747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.
    Lebecque S; Dolecek C; Laffer S; Visco V; Denépoux S; Pin JJ; Guret C; Boltz-Nitulescu G; Weyer A; Valenta R
    J Allergy Clin Immunol; 1997 Mar; 99(3):374-84. PubMed ID: 9058694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1.
    Mirza O; Henriksen A; Ipsen H; Larsen JN; Wissenbach M; Spangfort MD; Gajhede M
    J Immunol; 2000 Jul; 165(1):331-8. PubMed ID: 10861069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-Specific Lipid Transfer Protein Amb a 6 Is a Source-Specific Important Allergenic Molecule in Ragweed Pollen.
    Grijincu M; Tănasie G; Zbîrcea LE; Buzan MR; Tamaș TP; Cotarcă MD; Huțu I; Babaev E; Stolz F; Dorofeeva Y; Valenta R; Păunescu V; Panaitescu C; Chen KW
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
    Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
    J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
    Campana R; Vrtala S; Maderegger B; Dall'Antonia Y; Zafred D; Blatt K; Herrmann H; Focke-Tejkl M; Swoboda I; Scheiblhofer S; Gieras A; Neubauer A; Keller W; Valent P; Thalhamer J; Spitzauer S; Valenta R
    Mol Immunol; 2011 Jan; 48(4):431-41. PubMed ID: 21093057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
    Stumvoll S; Lidholm J; Thunberg R; DeWitt AM; Eibensteiner P; Swoboda I; Bugajska-Schretter A; Spitzauer S; Vangelista L; Kazemi-Shirazi L; Sperr WR; Valent P; Kraft D; Valenta R
    Biol Chem; 2002 Sep; 383(9):1383-96. PubMed ID: 12437131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment.
    Levin M; Rydnert F; Källström E; Tan LW; Wormald PJ; Lindstedt M; Greiff L; Ohlin M
    J Immunol; 2013 Jul; 191(2):551-60. PubMed ID: 23761636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
    Edlmayr J; Niespodziana K; Linhart B; Focke-Tejkl M; Westritschnig K; Scheiblhofer S; Stoecklinger A; Kneidinger M; Valent P; Campana R; Thalhamer J; Popow-Kraupp T; Valenta R
    J Immunol; 2009 May; 182(10):6298-306. PubMed ID: 19414783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5.
    Focke-Tejkl M; Campana R; Reininger R; Lupinek C; Blatt K; Valent P; Pavkov-Keller T; Keller W; Valenta R
    J Allergy Clin Immunol; 2014 Mar; 133(3):836-45.e11. PubMed ID: 24182774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
    Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
    Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy.
    Flicker S; Linhart B; Wild C; Wiedermann U; Valenta R
    Immunobiology; 2013 Jun; 218(6):884-91. PubMed ID: 23182706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
    Akinfenwa O; Huang HJ; Linhart B; Focke-Tejkl M; Vrtala S; Poroshina A; Nikonova A; Khaitov M; Campion NJ; Eckl-Dorna J; Niederberger-Leppin V; Kratzer B; Tauber PA; Pickl WF; Kundi M; Campana R; Valenta R
    Front Immunol; 2021; 12():744544. PubMed ID: 34795666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of Phl p 1, Phl p 5, Phl p 7 and Phl p 12 specific IgE antibodies in the sera of children and adult patients allergic to Phleum pollen.
    Sekerkova A; Polackova M; Striz I
    Allergol Int; 2012 Jun; 61(2):339-46. PubMed ID: 22526205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin).
    Ebner C; Hirschwehr R; Bauer L; Breiteneder H; Valenta R; Ebner H; Kraft D; Scheiner O
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):962-9. PubMed ID: 7751517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.